Market Dynamics and Financial Trajectory for Angelica Sinensis in the Pharmaceutical Sector
Introduction
Angelica sinensis, commonly known as Dong Quai, is a traditional Chinese herbal medicine that has been gaining significant attention in the pharmaceutical industry due to its diverse medicinal properties. Here, we delve into the market dynamics and financial trajectory of Angelica sinensis, particularly focusing on its use as a pharmaceutical excipient.
Traditional Use and Medicinal Properties
Angelica sinensis has been used for centuries in traditional Chinese medicine for various indications, including enriching blood, activating blood circulation, regulating menstruation, relieving pain, and relaxing bowels. Its pharmacodynamic and pharmacokinetic properties make it a valuable ingredient in herbal medicinal products[1].
Market Size and Growth
The global market for Angelica sinensis extract is projected to grow significantly. As of 2023, the market was estimated to be worth US$ 390 million and is forecasted to reach US$ 592.9 million by 2030, with a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period 2024-2030[2].
Key Players and Market Segmentation
The market for Angelica sinensis extract is dominated by several key players, including Xian Yuensun Biological Technology Co., Ltd., Naturalin Bio-Resources Co., Ltd, Etchem, NaturMed Scientific, and SHENYANG FADA PHARM CO., LTD., among others. The market is segmented by type (powder and liquid) and application (medicine, health products, and others)[2].
Applications in Pharmaceutical Products
Angelica sinensis is used in various pharmaceutical products due to its anti-inflammatory, antitumor, and anti-metastasis properties. The active ingredients, particularly phthalides such as Z-ligustilide, n-butylidenephthalide, and senkyunolide A, have shown significant synergy in anti-cancer effects[4].
Anti-Cancer Properties
Studies have demonstrated that the supercritical fluid extract of Angelica sinensis (A-SFE) exhibits a strong anti-cancer effect, especially against colorectal cancer. This makes it a potential natural resource in cancer treatment[4].
Other Medicinal Uses
In addition to its anti-cancer properties, Angelica sinensis is used to treat menstrual disorders, constipation, traumatic injuries, and other conditions. Its ability to regulate blood circulation and relieve pain further expands its pharmaceutical applications[1].
Extraction and Processing
The extraction process of Angelica sinensis involves traditional methods as well as modern techniques such as supercritical fluid extraction. This method ensures the effective extraction of active ingredients while maintaining their potency[4].
Regulatory Status
In the European Union, there are no monocomponent medicinal products containing Angelica sinensis radix or its preparations. However, it is widely used in food supplements and traditional combination herbal medicinal products. The regulatory status varies by country, with most countries not having specific medicinal products but allowing its use in food supplements[1].
Market Drivers
Several factors drive the growth of the Angelica sinensis market:
- Increasing Demand for Natural Products: The growing preference for natural and herbal remedies is a significant driver.
- Pharmaceutical Excipients Market Growth: The overall growth in the pharmaceutical excipients market, driven by the demand for generic drugs and patient-centric formulations, also benefits Angelica sinensis[3].
- Research and Development: Continuous R&D investments in extracting and utilizing the active ingredients of Angelica sinensis enhance its market potential.
Market Barriers
Despite the growth potential, there are several barriers to consider:
- Regulatory Stringency: Strict regulatory requirements can hinder the approval and market entry of new products containing Angelica sinensis.
- High Development Costs: The cost of extracting and processing Angelica sinensis, especially using advanced methods like supercritical fluid extraction, can be high[3].
Financial Trajectory
The financial trajectory of Angelica sinensis is promising, with a projected market size of US$ 592.9 million by 2030. This growth is supported by increasing demand, expanding applications, and advancements in extraction technologies.
Revenue Forecast
The revenue forecast indicates a steady growth rate, driven by the increasing adoption of Angelica sinensis in pharmaceutical and health products. The CAGR of 5.5% during the forecast period 2024-2030 reflects the market's potential for sustained growth[2].
Competitive Landscape
The competitive landscape is characterized by a mix of established and emerging players. Companies like Xian Yuensun Biological Technology Co., Ltd. and Naturalin Bio-Resources Co., Ltd. are key players, and the market is expected to see more entrants as the demand for natural excipients increases[2].
Conclusion
Angelica sinensis is poised to play a significant role in the pharmaceutical industry, driven by its diverse medicinal properties and growing market demand. The projected market size and growth rate indicate a promising financial trajectory, despite some regulatory and developmental challenges.
Key Takeaways
- Growing Market Size: The global market for Angelica sinensis extract is expected to reach US$ 592.9 million by 2030.
- Diverse Applications: Angelica sinensis is used in various pharmaceutical products, including anti-cancer treatments and menstrual disorder remedies.
- Advanced Extraction Methods: Supercritical fluid extraction enhances the potency and efficacy of Angelica sinensis extracts.
- Regulatory Considerations: Strict regulatory requirements need to be navigated for market approval.
- Competitive Landscape: Established and emerging players are driving the market forward.
FAQs
What is the projected market size of Angelica sinensis extract by 2030?
The global market for Angelica sinensis extract is forecasted to reach US$ 592.9 million by 2030[2].
What are the main applications of Angelica sinensis in pharmaceutical products?
Angelica sinensis is used in medicine, health products, and other applications, particularly for its anti-cancer, anti-inflammatory, and menstrual disorder treatment properties[2].
Who are the key players in the Angelica sinensis extract market?
Key players include Xian Yuensun Biological Technology Co., Ltd., Naturalin Bio-Resources Co., Ltd, Etchem, NaturMed Scientific, and SHENYANG FADA PHARM CO., LTD.[2].
What extraction method is commonly used for Angelica sinensis?
Supercritical fluid extraction is a modern and effective method used to extract the active ingredients from Angelica sinensis[4].
What are the regulatory challenges for Angelica sinensis products in the EU?
There are no monocomponent medicinal products containing Angelica sinensis radix or its preparations in the EU, and regulatory status varies by country, with strict requirements for market approval[1].
Sources
- EMA/HMPC/614586/2012 Committee on Herbal Medicinal Products (HMPC) Assessment report on Angelica sinensis (Oliv.) Diels, radix.
- Valuates Reports - Angelica Sinensis Extract - Market Size.
- MarketsandMarkets - Pharmaceutical Excipients Market Growth, Drivers, and Opportunities.
- Frontiers in Pharmacology - Supercritical fluid extract of Angelica sinensis promotes the anti-CRC effect.
